BEAM
Beam Therapeutics Inc.Open24.50−0.63 −2.51%USD
NasdaqGS · as of Oct 13, 14:52 ET · 15m delay
Open
24.84
Prev close
25.13
Day range
24.0924.93
52-week range
20.2338.26
Volume
917.09K0.49×
Mkt cap
2.53B
P/E ttm
—
Fwd P/E
-5.17
EPS ttm
-0.6800
Div yield
0.00%
Earnings
Aug 4, 2026
From 52w high
−35.96%
BEAM market-implied price distribution
BEAM Price at Expiry
30 OTM quotes · ATM IV 94.3%
Days to expiry
38
Fri, Nov 20, 2026
P(finish above spot)
42%
spot 24.50
Expected price
25.31
forward 24.73
68% range
18–30
−27.1% / +20.7%
Shaded band: the middle 68% of outcomes. Where the blue curve sits above the dashed one, options price that move as likelier than a plain bell curve would.
Target Price
Percentiles
| Chance below | Price | vs spot |
|---|---|---|
| 5% | 11.93 | −51.3% |
| 16% | 17.86 | −27.1% |
| 25% | 20.33 | −17.0% |
| 50% (median) | 23.61 | −3.6% |
| 75% | 27.06 | +10.5% |
| 84% | 29.58 | +20.7% |
| 95% | 49.17 | +100.7% |
Move Odds
| Up 5% or more (25.73) | 33% |
|---|---|
| Up 10% or more (26.95) | 26% |
| Down 5% or more (23.28) | 47% |
| Down 10% or more (22.05) | 37% |
Options price a 10%+ drop at 37%, 0.9× the 41% a bell curve with the same volatility gives.
Risk-neutral odds from option prices, the bot's lgf odds method: out-of-the-money mids → implied vols → a smoothed smile in total variance → density = erT·∂²C/∂K² (Breeden–Litzenberger). Risk-neutral odds include the market's risk premium, so they lean bearish compared with real-world odds. Not investment advice.